Shopping Cart 0
Cart Subtotal
USD 0

Non-Animal Alternatives Testing Market Global Report 2020-30

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

The non-animal alternatives testing market consists of sales of non-animal alternatives testing products and services that do not involve the use of animals for tests to determine the safety standards for products. The non-animal alternatives testing market involves testing for drugs, cosmetic products using non- animal testing methods. Organs-on-chip, In-vitro test, In-silico test are some examples of techniques and methodologies used as an alternative to animal testing.
 
The global non-animal alternatives testing market was worth USD 1.11 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 11.62% and reach USD 1.65 billion by 2023.
 
The alternative to animal testing market covered in this report is segmented by technology into cell culture technology; high throughput technology; molecular imaging; omics technology. It is also segmented by method into cellular assay; biochemical assay; in silico; ex-vivo and by end-user into pharmaceutical industry; cosmetics & household products; diagnostics; chemicals industry; food industry.
 
The support from the government and non-governmental organisations boosts the growth of the non-animal testing market. The government organisations enforces laws and regulations, raises funds to support the non-animal testing methods such as tests on human volunteers, advanced computer-modelling techniques and also funds studies with human volunteer. In order to support the non-animal testing, US Environmental Protection Agency (EPA), in 2019, awarded USD 4.25 million to the USA based universities including Johns Hopkins University, Vanderbilt University, Oregon State University, and the University of California to research for alternative tests replacing animals with non-animal alternatives and to make the test procedures less painful to the laboratory animals. Similar research programs to promote non-animal testing procedures are also initiated by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China and Korea. The constant support from the government drives the growth of the non-animal testing market.
 
Compulsory animal testing is required for the approval of sale of various products such as the pesticides, industrial chemicals, drugs, medical devices, vaccines, genetically modified foods, and some consumer products. Animal testing is still a mandatory practice in some countries due to their legal system where any special use products, non- routine tests, imported cosmetic requires animal testing. For instance, according to the UK's annual statistics of scientific procedures on living animals, in 2018, a total of 3.52 million experiments were completed on animals. According to Cruelty Free International, in 2018, in the UK almost 40 eye irritation tests, 10,275 acute lethal toxicity tests, and 638 pyrogenicity experiments were conducted on live rabbits. Cruelty Free International is an U.K based animal protection and advocacy group. The legal requirements in some countries for compulsory animal testing will hamper the growth of the market.
 
The companies in the non-animal testing market are increasingly investing in technologies such as organs on the chip technology as an alternative to animal testing. Organs- on the- chip method contains human cells on a chip which mimics the structure and function of human organs and organs system instead of using of animal for the test. Following the trend, in 2018, Emulate was funded an amount of USD 36 million from its founder's fund and ALS Investment Fund, SciFi VC, GlassWall Syndicate Association to extended its biological capabilities to Liver-Chip, Intestine-Chip, Lung-Chip, and Brain-Chip, and to its human-relevant models of thrombosis and immune system modulation. ALS Investment Fund, SciFi VC and GlassWall Syndicate Association are venture capital and private equity firm that supports and finances biotech companies.
 
In 2018, Thermo Fisher Scientific Inc., a USA based life sciences research company, acquired Advanced Bioprocessing business from Becton, Dickinson and Company for USD 477 million in cash. Through this acquistion Thermo Fisher Scientific Inc. aimed to expand its bioproduction portfolio by utilising the cell-culture media products of the Becton, Dickinson and Company. The Becton, Dickinson and Company is a USA based medical device company.
 
Major players in the market are H�Rel Corporation, Cyprotex, VITROCELL, SIMULAB, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratoriesand Gentronix Limited.
READ MORE

Table Of Content

Scope

1. Executive Summary

2. Non-Animal Alternatives Testing Market Characteristics

3. Non-Animal Alternatives Testing Market Size And Growth

3.1. Global Non-Animal Alternatives Testing Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Non-Animal Alternatives Testing Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Non-Animal Alternatives Testing Market Segmentation

4.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Cell Culture Technology

High Throughput Technology

Molecular Imaging

Omics Technology

4.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Cellular Assay

Biochemical Assay

In Silico

Ex-vivo

4.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Pharmaceutical Industry

Cosmetics & Household Products

Diagnostics

Chemicals Industry

Food Industry

5. Non-Animal Alternatives Testing Market Regional And Country Analysis

5.1. Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Non-Animal Alternatives Testing Market

6.1. Asia-Pacific Non-Animal Alternatives Testing Market Overview

6.2. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6.3. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Non-Animal Alternatives Testing Market

7.1. China Non-Animal Alternatives Testing Market Overview

7.2. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

7.3. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Non-Animal Alternatives Testing Market

8.1. India Non-Animal Alternatives Testing Market Overview

8.2. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

8.3. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Non-Animal Alternatives Testing Market

9.1. Japan Non-Animal Alternatives Testing Market Overview

9.2. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9.3. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Non-Animal Alternatives Testing Market

10.1. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10.2. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Non-Animal Alternatives Testing Market

11.1. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11.2. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Non-Animal Alternatives Testing Market

12.1. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12.2. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Non-Animal Alternatives Testing Market

13.1. Western Europe Non-Animal Alternatives Testing Market Overview

13.2. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13.3. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Non-Animal Alternatives Testing Market

14.1. UK Non-Animal Alternatives Testing Market Overview

14.2. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14.3. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Non-Animal Alternatives Testing Market

15.1. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15.2. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Non-Animal Alternatives Testing Market

16.4. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16.5. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Non-Animal Alternatives Testing Market

17.1. Eastern Europe Non-Animal Alternatives Testing Market Overview

17.2. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17.3. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Non-Animal Alternatives Testing Market

18.1. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18.2. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Non-Animal Alternatives Testing Market

19.1. North America Non-Animal Alternatives Testing Market Overview

19.2. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19.3. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Non-Animal Alternatives Testing Market

20.1. USA Non-Animal Alternatives Testing Market Overview

20.2. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20.3. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Non-Animal Alternatives Testing Market

21.1. South America Non-Animal Alternatives Testing Market Overview

21.2. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21.3. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Non-Animal Alternatives Testing Market

22.1. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22.2. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Non-Animal Alternatives Testing Market

23.1. Middle East Non-Animal Alternatives Testing Market Overview

23.2. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23.3. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Non-Animal Alternatives Testing Market

24.1. Africa Non-Animal Alternatives Testing Market Overview

24.2. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24.3. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Non-Animal Alternatives Testing Market Competitive Landscape And Company Profiles

25.1. Non-Animal Alternatives Testing Market Competitive Landscape

25.2. Non-Animal Alternatives Testing Market Company Profiles

25.2.1. H�Rel Corporation

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Cyprotex

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. VITROCELL

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. SIMULAB

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Bio-Rad Laboratories

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Non-Animal Alternatives Testing Market

27. Non-Animal Alternatives Testing Market Trends And Strategies

28. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: China, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: China, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: India, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: India, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Japan, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: Japan, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Australia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: Australia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: South Korea, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: South Korea, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: UK, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: UK, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Germany, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 27: Germany, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 28: France, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 29: France, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 30: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 31: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 32: Russia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 33: Russia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 34: North America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 35: North America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 36: USA, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 37: USA, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 38: South America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 39: South America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 40: Brazil, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 41: Brazil, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 42: Middle East, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 43: Middle East, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 44: Africa, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 45: Africa, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 46: H�Rel Corporation Financial Performance

Figure 47: Cyprotex Financial Performance

Figure 48: VITROCELL Financial Performance

Figure 49: SIMULAB Financial Performance

Figure 50: Bio-Rad Laboratories Financial Performance


List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: China, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: China, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: India, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: India, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Japan, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: Japan, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Australia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: Australia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: South Korea, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: South Korea, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: UK, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: UK, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Germany, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 27: Germany, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 28: France, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 29: France, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 30: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 31: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 32: Russia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 33: Russia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 34: North America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 35: North America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 36: USA, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 37: USA, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 38: South America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 39: South America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 40: Brazil, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 41: Brazil, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 42: Middle East, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 43: Middle East, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 44: Africa, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 45: Africa, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 46: H�Rel Corporation Financial Performance

Table 47: Cyprotex Financial Performance

Table 48: VITROCELL Financial Performance

Table 49: SIMULAB Financial Performance

Table 50: Bio-Rad Laboratories Financial Performance

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; 2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-vivo; 3) By End-User: Pharmaceutical Industry; Cosmetics & Household Products; Diagnostics; Chemicals Industry; Food Industry


Companies

H�Rel Corporation; Cyprotex; VITROCELL; SIMULAB; Bio-Rad Laboratories; GE Healthcare; SGS SA; BioIVT; Abbott Laboratories; Gentronix Limited; Promega Corporation; MB Research Laboratories; Qiagen N.V.; Urban Decay; Catalent, Inc.; Evotec AG (Cyprotex plc); Ecotec AG (Cyprotex plc); Catalent, Inc; Thermo Fisher Scientific; Laboratory Corporation of America Holdings; Charles River Laboratories, Inc.; Agilent Technologies, Inc.; BioReliance Corporation (a subsidiary of Merck KGaA); Ecco Bella; Bare Blossom; Billy Jealousy; MuLondon Organic; Modern Minerals Makeup; BiomimX SRL; Elveflow; Emulate Inc.

Company Profile

Company Profile Title

The non-animal alternatives testing market consists of sales of non-animal alternatives testing products and services that do not involve the use of animals for tests to determine the safety standards for products. The non-animal alternatives testing market involves testing for drugs, cosmetic products using non- animal testing methods. Organs-on-chip, In-vitro test, In-silico test are some examples of techniques and methodologies used as an alternative to animal testing.
 
The global non-animal alternatives testing market was worth USD 1.11 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 11.62% and reach USD 1.65 billion by 2023.
 
The alternative to animal testing market covered in this report is segmented by technology into cell culture technology; high throughput technology; molecular imaging; omics technology. It is also segmented by method into cellular assay; biochemical assay; in silico; ex-vivo and by end-user into pharmaceutical industry; cosmetics & household products; diagnostics; chemicals industry; food industry.
 
The support from the government and non-governmental organisations boosts the growth of the non-animal testing market. The government organisations enforces laws and regulations, raises funds to support the non-animal testing methods such as tests on human volunteers, advanced computer-modelling techniques and also funds studies with human volunteer. In order to support the non-animal testing, US Environmental Protection Agency (EPA), in 2019, awarded USD 4.25 million to the USA based universities including Johns Hopkins University, Vanderbilt University, Oregon State University, and the University of California to research for alternative tests replacing animals with non-animal alternatives and to make the test procedures less painful to the laboratory animals. Similar research programs to promote non-animal testing procedures are also initiated by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China and Korea. The constant support from the government drives the growth of the non-animal testing market.
 
Compulsory animal testing is required for the approval of sale of various products such as the pesticides, industrial chemicals, drugs, medical devices, vaccines, genetically modified foods, and some consumer products. Animal testing is still a mandatory practice in some countries due to their legal system where any special use products, non- routine tests, imported cosmetic requires animal testing. For instance, according to the UK's annual statistics of scientific procedures on living animals, in 2018, a total of 3.52 million experiments were completed on animals. According to Cruelty Free International, in 2018, in the UK almost 40 eye irritation tests, 10,275 acute lethal toxicity tests, and 638 pyrogenicity experiments were conducted on live rabbits. Cruelty Free International is an U.K based animal protection and advocacy group. The legal requirements in some countries for compulsory animal testing will hamper the growth of the market.
 
The companies in the non-animal testing market are increasingly investing in technologies such as organs on the chip technology as an alternative to animal testing. Organs- on the- chip method contains human cells on a chip which mimics the structure and function of human organs and organs system instead of using of animal for the test. Following the trend, in 2018, Emulate was funded an amount of USD 36 million from its founder's fund and ALS Investment Fund, SciFi VC, GlassWall Syndicate Association to extended its biological capabilities to Liver-Chip, Intestine-Chip, Lung-Chip, and Brain-Chip, and to its human-relevant models of thrombosis and immune system modulation. ALS Investment Fund, SciFi VC and GlassWall Syndicate Association are venture capital and private equity firm that supports and finances biotech companies.
 
In 2018, Thermo Fisher Scientific Inc., a USA based life sciences research company, acquired Advanced Bioprocessing business from Becton, Dickinson and Company for USD 477 million in cash. Through this acquistion Thermo Fisher Scientific Inc. aimed to expand its bioproduction portfolio by utilising the cell-culture media products of the Becton, Dickinson and Company. The Becton, Dickinson and Company is a USA based medical device company.
 
Major players in the market are H�Rel Corporation, Cyprotex, VITROCELL, SIMULAB, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratoriesand Gentronix Limited.
READ MORE

Scope

1. Executive Summary

2. Non-Animal Alternatives Testing Market Characteristics

3. Non-Animal Alternatives Testing Market Size And Growth

3.1. Global Non-Animal Alternatives Testing Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Non-Animal Alternatives Testing Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Non-Animal Alternatives Testing Market Segmentation

4.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Cell Culture Technology

High Throughput Technology

Molecular Imaging

Omics Technology

4.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Cellular Assay

Biochemical Assay

In Silico

Ex-vivo

4.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Pharmaceutical Industry

Cosmetics & Household Products

Diagnostics

Chemicals Industry

Food Industry

5. Non-Animal Alternatives Testing Market Regional And Country Analysis

5.1. Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Non-Animal Alternatives Testing Market

6.1. Asia-Pacific Non-Animal Alternatives Testing Market Overview

6.2. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6.3. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Non-Animal Alternatives Testing Market

7.1. China Non-Animal Alternatives Testing Market Overview

7.2. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

7.3. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Non-Animal Alternatives Testing Market

8.1. India Non-Animal Alternatives Testing Market Overview

8.2. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

8.3. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Non-Animal Alternatives Testing Market

9.1. Japan Non-Animal Alternatives Testing Market Overview

9.2. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9.3. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Non-Animal Alternatives Testing Market

10.1. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10.2. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Non-Animal Alternatives Testing Market

11.1. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11.2. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Non-Animal Alternatives Testing Market

12.1. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12.2. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Non-Animal Alternatives Testing Market

13.1. Western Europe Non-Animal Alternatives Testing Market Overview

13.2. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13.3. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Non-Animal Alternatives Testing Market

14.1. UK Non-Animal Alternatives Testing Market Overview

14.2. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14.3. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Non-Animal Alternatives Testing Market

15.1. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15.2. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Non-Animal Alternatives Testing Market

16.4. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16.5. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Non-Animal Alternatives Testing Market

17.1. Eastern Europe Non-Animal Alternatives Testing Market Overview

17.2. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17.3. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Non-Animal Alternatives Testing Market

18.1. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18.2. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Non-Animal Alternatives Testing Market

19.1. North America Non-Animal Alternatives Testing Market Overview

19.2. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19.3. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Non-Animal Alternatives Testing Market

20.1. USA Non-Animal Alternatives Testing Market Overview

20.2. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20.3. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Non-Animal Alternatives Testing Market

21.1. South America Non-Animal Alternatives Testing Market Overview

21.2. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21.3. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Non-Animal Alternatives Testing Market

22.1. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22.2. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Non-Animal Alternatives Testing Market

23.1. Middle East Non-Animal Alternatives Testing Market Overview

23.2. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23.3. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Non-Animal Alternatives Testing Market

24.1. Africa Non-Animal Alternatives Testing Market Overview

24.2. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24.3. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Non-Animal Alternatives Testing Market Competitive Landscape And Company Profiles

25.1. Non-Animal Alternatives Testing Market Competitive Landscape

25.2. Non-Animal Alternatives Testing Market Company Profiles

25.2.1. H�Rel Corporation

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Cyprotex

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. VITROCELL

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. SIMULAB

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Bio-Rad Laboratories

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Non-Animal Alternatives Testing Market

27. Non-Animal Alternatives Testing Market Trends And Strategies

28. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: China, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: China, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: India, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: India, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Japan, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: Japan, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Australia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: Australia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: South Korea, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: South Korea, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: UK, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: UK, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Germany, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 27: Germany, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 28: France, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 29: France, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 30: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 31: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 32: Russia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 33: Russia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 34: North America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 35: North America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 36: USA, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 37: USA, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 38: South America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 39: South America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 40: Brazil, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 41: Brazil, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 42: Middle East, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 43: Middle East, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 44: Africa, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 45: Africa, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 46: H�Rel Corporation Financial Performance

Figure 47: Cyprotex Financial Performance

Figure 48: VITROCELL Financial Performance

Figure 49: SIMULAB Financial Performance

Figure 50: Bio-Rad Laboratories Financial Performance


List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: Asia-Pacific, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: China, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: China, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: India, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: India, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Japan, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: Japan, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Australia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: Australia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Indonesia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: South Korea, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: South Korea, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Western Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: UK, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: UK, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Germany, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 27: Germany, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 28: France, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 29: France, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 30: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 31: Eastern Europe, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 32: Russia, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 33: Russia, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 34: North America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 35: North America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 36: USA, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 37: USA, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 38: South America, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 39: South America, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 40: Brazil, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 41: Brazil, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 42: Middle East, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 43: Middle East, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 44: Africa, Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 45: Africa, Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 46: H�Rel Corporation Financial Performance

Table 47: Cyprotex Financial Performance

Table 48: VITROCELL Financial Performance

Table 49: SIMULAB Financial Performance

Table 50: Bio-Rad Laboratories Financial Performance

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; 2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-vivo; 3) By End-User: Pharmaceutical Industry; Cosmetics & Household Products; Diagnostics; Chemicals Industry; Food Industry


Companies

H�Rel Corporation; Cyprotex; VITROCELL; SIMULAB; Bio-Rad Laboratories; GE Healthcare; SGS SA; BioIVT; Abbott Laboratories; Gentronix Limited; Promega Corporation; MB Research Laboratories; Qiagen N.V.; Urban Decay; Catalent, Inc.; Evotec AG (Cyprotex plc); Ecotec AG (Cyprotex plc); Catalent, Inc; Thermo Fisher Scientific; Laboratory Corporation of America Holdings; Charles River Laboratories, Inc.; Agilent Technologies, Inc.; BioReliance Corporation (a subsidiary of Merck KGaA); Ecco Bella; Bare Blossom; Billy Jealousy; MuLondon Organic; Modern Minerals Makeup; BiomimX SRL; Elveflow; Emulate Inc.